| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4522 | 2018 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2230 | 2018 |
| The functional impact of alternative splicing in cancer H Climente-González, E Porta-Pardo, A Godzik, E Eyras Cell reports 20 (9), 2215-2226, 2017 | 529 | 2017 |
| A structural biology community assessment of AlphaFold 2 applications M Akdel, DEV Pires, EP Pardo, J Jänes, AO Zalevsky, B Mészáros, ... Nature Structural and Molecular Biology 29, 1056-1067, 2022 | 390 | 2022 |
| Perspective on oncogenic processes at the end of the beginning of cancer genomics L Ding, MH Bailey, E Porta-Pardo, V Thorsson, A Colaprico, D Bertrand, ... Cell 173 (2), 305-320. e10, 2018 | 366 | 2018 |
| A pan-cancer catalogue of cancer driver protein interaction interfaces E Porta-Pardo, L Garcia-Alonso, T Hrabe, J Dopazo, A Godzik PLoS computational biology 11 (10), e1004518, 2015 | 141 | 2015 |
| e-Driver: a novel method to identify protein regions driving cancer E Porta-Pardo, A Godzik Bioinformatics 30 (21), 3109-3114, 2014 | 136 | 2014 |
| Germline genetic contribution to the immune landscape of cancer RW Sayaman, M Saad, V Thorsson, D Hu, W Hendrickx, J Roelands, ... Immunity 54 (2), 367-386. e8, 2021 | 120 | 2021 |
| Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens M Giménez-Barcons, A Casteras, MP Armengol, E Porta, PA Correa, ... The Journal of Immunology 193 (8), 3872-3879, 2014 | 114 | 2014 |
| Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group L De Mattos-Arruda, M Vazquez, F Finotello, R Lepore, E Porta, J Hundal, ... Annals of oncology 31 (8), 978-990, 2020 | 98 | 2020 |
| Comparison of algorithms for the detection of cancer drivers at subgene resolution. E Porta-Pardo, A Kamburov, D Tamborero, T Pons, D Grases, A Valencia, ... Nature Methods, 2017 | 85 | 2017 |
| The structural coverage of the human proteome before and after AlphaFold E Porta-Pardo, V Ruiz-Serra, S Valentini, A Valencia PLoS computational biology 18 (1), e1009818, 2022 | 83 | 2022 |
| Cancer3D: understanding cancer mutations through protein structures E Porta-Pardo, T Hrabe, A Godzik Nucleic Acids Research, 2014 | 57 | 2014 |
| Mutation Drivers of Immunological Responses to Cancer E Porta-Pardo, A Godzik Cancer immunology research 4 (9), 789-798, 2016 | 38 | 2016 |
| Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era E Porta‐Pardo, A Valencia, A Godzik FEBS letters 594 (24), 4233-4246, 2020 | 31 | 2020 |
| Pan-cancer proteogenomics connects oncogenic drivers to functional states Y Li, E Porta-Pardo, C Tokheim, MH Bailey, TM Yaron, V Stathias, ... Cell 186 (18), 3921-3944. e25, 2023 | 25 | 2023 |
| AIRE genetic variants and predisposition to polygenic autoimmune disease: The case of Graves’ disease and a systematic literature review R Colobran, M Giménez-Barcons, A Marín-Sánchez, E Porta-Pardo, ... Human Immunology 77 (8), 643-651, 2016 | 24 | 2016 |
| Epigenetic regulation during cancer transitions across 11 tumour types NV Terekhanova, A Karpova, WW Liang, A Strzalkowski, S Chen, Y Li, ... Nature 623 (7986), 432-441, 2023 | 18 | 2023 |
| Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin WW Liang, RJH Lu, RG Jayasinghe, SM Foltz, E Porta-Pardo, Y Geffen, ... Cancer cell 41 (9), 1567-1585. e7, 2023 | 15 | 2023 |
| Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools C Garcia-Prieto, F Martínez-Jiménez, A Valencia, E Porta-Pardo Bioinformatics, 2022 | 13* | 2022 |
Adam GodzikProfessor, University of California Riverside School of Medicine在 medsch.ucr.edu 的电子邮件经过验证
